M&A Deal Summary

Parallel Acquires New England Treatment Access

On January 14, 2019, Parallel acquired consumer products company New England Treatment Access

Acquisition Highlights
  • This is Parallel’s 1st transaction in the Consumer Products sector.
  • This is Parallel’s 1st transaction in the United States.
  • This is Parallel’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2019-01-14
Target New England Treatment Access
Sector Consumer Products
Buyer(s) Parallel
Deal Type Add-on Acquisition

Target

New England Treatment Access

Franklin, Massachusetts, United States
New England Treatment Access LLC provides licensed patients in Massachusetts with first-rate marijuana therapies at our registered medical marijuana dispensaries in Brookline and Northampton.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Parallel

Atlanta, Georgia, United States
Category Company
Founded 2014
Sector Consumer Products
DESCRIPTION

Parallel provides cannabis-based natural products to support wellness. Parallel was founded in 2014 and is based in Atlanta, Georgia.

DEAL STATS #
Overall 1 of 3
Sector (Consumer Products) 1 of 2
Type (Add-on Acquisition) 1 of 3
State (Massachusetts) 1 of 1
Country (United States) 1 of 3
Year (2019) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-25 Molecular Infusions

Los Angeles, California, United States

Molecular Infusions LLC is a biopharmaceutical company based in Massachusetts committed to improving lives by advancing cannabis therapies through the deployment of proprietary technologies, scientific rigor, and results-driven innovation. Molecular Infusions was founded in 2016 and is based in Los Angeles, California.

Buy -
Mergr

Product

Company

Legal